John Brancaccio - May 16, 2022 Form 3 Insider Report for OKYO Pharma Ltd (OKYO)

Role
Director
Signature
/s/ John Brancaccio
Stock symbol
OKYO
Transactions as of
May 16, 2022
Transactions value $
$0
Form type
3
Date filed
5/16/2022, 05:47 PM
Previous filing
Mar 10, 2022
Next filing
Jun 9, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OKYO Option (right to buy) May 16, 2022 Ordinary Shares 450K $0.20 Direct F1
holding OKYO Option (right to buy) May 16, 2022 Ordinary Shares 900K $0.06 Direct F2
holding OKYO Option (right to buy) May 16, 2022 Ordinary Shares 100K $0.10 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% will vest each year on June 10 beginning on August 20, 2020.
F2 25% will vest each year on June 10 beginning on August 31, 2021.
F3 Vests in equal amounts over 3 years beginning on January 31, 2022.